Integration of Melt Electrowritten Polymeric Scaffolds and Bioprinting for Epithelial Healing via Localized Periostin Delivery.
Nileshkumar DubeyMaedeh RahimnejadW Benton SwansonJinping XuMylène de RuijterJos MaldaCristiane H SquarizeRogerio M CastilhoMarco Cicero BottinoPublished in: ACS macro letters (2024)
Management of skin injuries imposes a substantial financial burden on patients and hospitals, leading to diminished quality of life. Periostin (rhOSF), an extracellular matrix component, regulates cell function, including a proliferative healing phase, representing a key protein to promote wound healing. Despite its proven efficacy in vitro , there is a lack of scaffolds that facilitate the in situ delivery of rhOSF. In addition, there is a need for a scaffold to not only support cell growth, but also to resist the mechanical forces involved in wound healing. In this work, we synthesized rhOSF-loaded mesoporous nanoparticles (MSNs) and incorporated them into a cell-laden gelatin methacryloyl (GelMA) ink that was bioprinted into melt electrowritten poly(ε-caprolactone) (PCL) microfibrous (MF-PCL) meshes to develop mechanically competent constructs. Diffraction light scattering (DLS) analysis showed a narrow nanoparticle size distribution with an average size of 82.7 ± 13.2 nm. The rhOSF-loaded hydrogels showed a steady and controlled release of rhOSF over 16 days at a daily dose of ∼40 ng/mL. Compared with blank MSNs, the incorporation of rhOSF markedly augmented cell proliferation, underscoring its contribution to cellular performance. Our findings suggest a promising approach to address challenges such as prolonged healing, offering a potential solution for developing robust, biocompatible, and cell-laden grafts for burn wound healing applications.
Keyphrases
- wound healing
- tissue engineering
- extracellular matrix
- cell proliferation
- single cell
- end stage renal disease
- drug delivery
- cell therapy
- chronic kidney disease
- ejection fraction
- newly diagnosed
- drug release
- healthcare
- cancer therapy
- risk factors
- physical activity
- cell cycle
- signaling pathway
- small molecule
- patient reported
- young adults
- data analysis
- virtual reality
- iron oxide